Showing results (31-40 of 113) with videos related to
Sort By:
Pageof 12
Platelets|April 12, 2016
Validation of a P2Y12-receptor specific whole blood platelet aggregation assayMichael Amann, Miroslaw Ferenc, Christian M Valina, et al.JACC. Cardiovascular Interventions|January 10, 2019
Impact of On-Clopidogrel Platelet Reactivity on Incidence of Hypoattenuated Leaflet Thickening After Transcatheter Aortic Valve ReplacementThomas G Nührenberg, Julia Hromek, Alexander Kille, et al.Thrombosis and Haemostasis|January 25, 2008
Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placementDietmar Trenk, Willibald Hochholzer, Devine Frundi, et al.Thrombosis and Haemostasis|January 6, 2018
Alteration of von Willebrand Factor after Transcatheter Aortic Valve Replacement in the Absence of Paravalvular RegurgitationFelix Pawlitschek, Cornelius Keyl, Barbara Zieger, et al.Platelets|December 11, 2012
Clopidogrel pretreatment of patients with ST-elevation myocardial infarction does not affect platelet reactivity after subsequent prasugrel-loading: platelet reactivity in an observational studyThomas G Nührenberg, Dietmar Trenk, Stefan Leggewie, et al.Journal of Cardiovascular Electrophysiology|November 1, 2013
Do atrial differences in endothelial damage, leukocyte and platelet activation, or tissue factor activity contribute to chamber-specific thrombogenic status in patients with atrial fibrillation?Laurence Jesel, Thomas Arentz, Claudia Herrera-Siklody, et al.International Journal of Cardiology|June 19, 2012
Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysisDániel Aradi, András Komócsi, Matthew J Price, et al.Platelets|September 14, 2018
Pharmacodynamic safety of clopidogrel monotherapy in patients under oral anticoagulation with a vitamin K antagonist undergoing coronary stent implantationChristian Valina, Timo Bömicke, Sherif Abdelrazek, et al.Circulation|April 6, 2005
Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary interventionWillibald Hochholzer, Dietmar Trenk, Devine Frundi, et al.Journal of the American College of Cardiology|June 1, 2010
Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placementWillibald Hochholzer, Dietmar Trenk, Martin F Fromm, et al.Pageof 12